JJ
Johnson & Johnson Portfolio holdings
AUM
$334M
This Quarter Return
-1.61%
1 Year Return
+16.18%
3 Year Return
+88.55%
5 Year Return
–
10 Year Return
–
AUM
$386M
AUM Growth
+$386M
(-9.6%)
Cap. Flow
+$352K
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
95.45%
Holding
21
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
Lyell Immunopharma
LYEL
|
$527K |
Top Sells
| 1 |
Clearside Biomedical
CLSD
|
$105K |
| 2 |
BiomX
PHGE
|
$69.7K |
Sector Composition
| 1 | Healthcare | 99.99% |
| 2 | Technology | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Protagonist Therapeutics
PTGX
$3.67B
| $94.5M | 24.48% | 2,449,183 | – | – |
|
2
CVRx
CVRX
$205M
| $52M | 13.46% | 4,103,430 | – | – |
|
|
RAPP
3
Rapport Therapeutics
RAPP
$643M
| $44.3M | 11.48% | 2,498,051 | – | – |
|
4
MeiraGTx Holdings
MGTX
$587M
| $40.4M | 10.47% | 6,641,064 | – | – |
|
|
CTNM
5
Contineum Therapeutics
CTNM
$293M
| $29M | 7.51% | 1,979,173 | – | – |
|
6
Procept Biorobotics
PRCT
$2.23B
| $28.8M | 7.46% | 357,939 | – | – |
|
7
Legend Biotech
LEGN
$6.41B
| $26.5M | 6.86% | 814,586 | – | – |
|
8
Neumora Therapeutics
NMRA
$280M
| $19.6M | 5.08% | 1,849,445 | – | – |
|
9
Xencor
XNCR
$580M
| $17.2M | 4.45% | 748,062 | – | – |
|
|
NBTX
10
Nanobiotix
NBTX
$429M
| $16.1M | 4.18% | 5,623,816 | – | – |
|
11
Fate Therapeutics
FATE
$120M
| $5.58M | 1.44% | 3,379,064 | – | – |
|
12
Arrowhead Research
ARWR
$3.05B
| $4.65M | 1.21% | 247,598 | – | – |
|
13
Rallybio
RLYB
$22.4M
| $3.49M | 0.9% | 3,636,363 | – | – |
|
14
Vor Biopharma
VOR
$250M
| $1.19M | 0.31% | 1,074,658 | – | – |
|
15
Nano X Imaging
NNOX
$247M
| $1.14M | 0.3% | 158,852 | – | – |
|
16
Standard BioTools
LAB
$481M
| $546K | 0.14% | 311,967 | – | – |
|
|
17
Lyell Immunopharma
LYEL
$213M
| $527K | 0.14% | +823,317 | New | +$527K |
|
18
Adicet Bio
ACET
$59.9M
| $351K | 0.09% | 364,472 | – | – |
|
|
19
BiomX
PHGE
$14.3M
| $70.7K | 0.02% | 96,866 -95,455 | -50% | -$69.7K |
|
20
Senseonics Holdings
SENS
$374M
| $28.6K | 0.01% | 54,621 | – | – |
|
|
21
Clearside Biomedical
CLSD
$28.9M
| – | – | -82,481 | Closed | -$105K |
|